Sanofi finishes buyout of Genzyme

04/10/2011 | Reuters

Sanofi-Aventis finalized a deal worth about $20.1 billion to take over Genzyme. The acquisition, which gives Sanofi access to Genzyme's orphan-drug business, will be partly funded through a $7 billion note offering.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations